BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26170328)

  • 1. Mutation-induced protein interaction kinetics changes affect apoptotic network dynamic properties and facilitate oncogenesis.
    Zhao L; Sun T; Pei J; Ouyang Q
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4046-54. PubMed ID: 26170328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parameter sensitivity analysis for a stochastic model of mitochondrial apoptosis pathway.
    Chen X; Li X; Zhao W; Li T; Ouyang Q
    PLoS One; 2018; 13(6):e0198579. PubMed ID: 29912904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energy management - a critical role in cancer induction?
    Garland J
    Crit Rev Oncol Hematol; 2013 Oct; 88(1):198-217. PubMed ID: 23731619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synonymous mutations in oncogenesis and apoptosis versus survival unveiled by network modeling.
    Li X; Chen Y; Qi H; Liu L; Shuai J
    Oncotarget; 2016 Jun; 7(23):34599-616. PubMed ID: 27129147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between oncogenic mutations and parameter sensitivity of the apoptosis pathway model.
    Chen J; Yue H; Ouyang Q
    PLoS Comput Biol; 2014 Jan; 10(1):e1003451. PubMed ID: 24465201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the structural and energetic basis of inhibitor and substrate bound to the full-length NS3/4A: insights from molecular dynamics simulation, binding free energy calculation and network analysis.
    Xue W; Wang M; Jin X; Liu H; Yao X
    Mol Biosyst; 2012 Oct; 8(10):2753-65. PubMed ID: 22833015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between cancer mutations and parameter sensitivity in Rb pathway.
    Chen X; Chen J; Shao B; Zhao L; Yue H; Ouyang Q
    J Theor Biol; 2016 Sep; 404():120-125. PubMed ID: 27181371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biophysical changes of ATP binding pocket may explain loss of kinase activity in mutant DAPK3 in cancer: A molecular dynamic simulation analysis.
    Agarwal T; Annamalai N; Maiti TK; Arsad H
    Gene; 2016 Apr; 580(1):17-25. PubMed ID: 26748242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing mutational and adaptive landscapes and the genesis of cancer.
    Liggett LA; DeGregori J
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):84-94. PubMed ID: 28167050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-related mutations in BRCA1-BRCT cause long-range structural changes in protein-protein binding sites: a molecular dynamics study.
    Gough CA; Gojobori T; Imanishi T
    Proteins; 2007 Jan; 66(1):69-86. PubMed ID: 17063491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
    Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
    Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core and specific network markers of carcinogenesis from multiple cancer samples.
    Wong YH; Chen RH; Chen BS
    J Theor Biol; 2014 Dec; 362():17-34. PubMed ID: 25016045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric network of cAMP-dependent protein kinase revealed by mutation of Tyr204 in the P+1 loop.
    Yang J; Garrod SM; Deal MS; Anand GS; Woods VL; Taylor S
    J Mol Biol; 2005 Feb; 346(1):191-201. PubMed ID: 15663937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis.
    Blanc-Brude OP; Mesri M; Wall NR; Plescia J; Dohi T; Altieri DC
    Clin Cancer Res; 2003 Jul; 9(7):2683-92. PubMed ID: 12855648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimentally guided structural modeling and dynamics analysis of Hsp90-p53 interactions: allosteric regulation of the Hsp90 chaperone by a client protein.
    Blacklock K; Verkhivker GM
    J Chem Inf Model; 2013 Nov; 53(11):2962-78. PubMed ID: 24191708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of JAK2 activation by Janus homology 2: evidence from molecular dynamics simulations.
    Wan S; Coveney PV
    J Chem Inf Model; 2012 Nov; 52(11):2992-3000. PubMed ID: 23033920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of point mutation on enzymatic activity: correlation between protein electronic structure and motion in chorismate mutase reaction.
    Ishida T
    J Am Chem Soc; 2010 May; 132(20):7104-18. PubMed ID: 20426479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Energetic and dynamic aspects of the affinity maturation process: characterizing improved variants from the bevacizumab antibody with molecular simulations.
    Corrada D; Colombo G
    J Chem Inf Model; 2013 Nov; 53(11):2937-50. PubMed ID: 24168661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intricate structural coordination and domain plasticity regulate activity of serine protease HtrA2.
    Chaganti LK; Kuppili RR; Bose K
    FASEB J; 2013 Aug; 27(8):3054-66. PubMed ID: 23608143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structural network of inflammation and cancer: merits and challenges.
    Guven Maiorov E; Keskin O; Gursoy A; Nussinov R
    Semin Cancer Biol; 2013 Aug; 23(4):243-51. PubMed ID: 23712403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.